Unitas Pharmaceuticals Private Limited

Manufacturer of GMP certified healthcare products including tablets, capsules, syrups, and more.

1994 | Central Delhi, Delhi (India) | Active
Last Updated:

Unitas Pharmaceuticals Profile

Key Indicators

  • Authorised Capital ₹ 6.00 M
  • Paid Up Capital ₹ 5.21 M
  • Company Age 31 Year, 26 Days
  • Last Filing with ROC 31 Mar 2023
  • Open Charges ₹ 5.13 Cr
  • Satisfied Charges ₹ 1.00 M
  • Revenue Growth -3.00%
  • Profit Growth 180.07%
  • Ebitda -9.59%
  • Net Worth 126.54%
  • Total Assets 1.95%

About Unitas Pharmaceuticals

Unitas Pharmaceuticals Private Limited (UPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 02 March 1994 and has a history of 31 years. Its registered office is in Central Delhi, Delhi, India.

The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 6.00 M and a paid-up capital of Rs 5.21 M.

The company currently has active open charges totaling ₹5.13 Cr. The company has closed loans amounting to ₹1.00 M, as per Ministry of Corporate Affairs (MCA) records.

Neelam Nijhawan and Akhilesh Nagar serve as directors at the Company.

Company Details

  • Location

    Central Delhi, Delhi, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    U74899DL1994PTC057671

  • Company No.

    057671

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    02 Mar 1994

  • Date of AGM

    29 Sep 2023

  • Date of Balance Sheet

    31 Mar 2023

  • Listing Status

    Unlisted

  • ROC Code

    Roc Delhi

Industry

Pharma

Who are the key members and board of directors at Unitas Pharmaceuticals?

Board Members (2)

NameDesignationAppointment DateStatus
Neelam Nijhawan Country flag representing In Director 14-Jan-2001Current
Akhilesh Nagar Country flag representing In Director 02-Mar-1994Current

Financial Performance of Unitas Pharmaceuticals.

Unitas Pharmaceuticals Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 3% decrease. The company also saw a substantial improvement in profitability, with a 180.07% increase in profit. The company's net worth Soared by an impressive increase of 126.54%.

Unitas Pharmaceuticals revenue growth over time
Unitas Pharmaceuticals profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
-3.00%
Revenue from Operations
-3.00%
Total Assets
1.95%
Profit or Loss
180.07%
Net Worth
126.54%
EBITDA
-9.59%

What is the Ownership and Shareholding Structure of Unitas Pharmaceuticals?

Unlock access to Unitas Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹51.30 M

Satisfied Charges

₹1.00 M

Charges Breakdown by Lending Institutions

  • Others : 2.74 Cr
  • State Bank Of India : 2.15 Cr
  • Hdfc Bank Limited : 0.24 Cr

Latest Charge Details

DateLenderAmountStatus
24 May 2023Hdfc Bank Limited₹2.43 MOpen
30 Jul 2013Others₹2.74 CrOpen
02 Apr 2003State Bank Of India₹2.15 CrOpen
28 Sep 1999Bank Of India₹0.25 MSatisfied
28 Sep 1999Bank Of India₹0.75 MSatisfied

How Many Employees Work at Unitas Pharmaceuticals?

Unlock and access historical data on people associated with Unitas Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee growth trends for Unitas Pharmaceuticals Private Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Unitas Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Unitas Pharmaceuticals's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Unitas Pharmaceuticals

Recent activity within the organization

  • Annual General Meeting

    Unitas Pharmaceuticals Private Limited last Annual general meeting of members was held on 29 Sep 2023 as per latest MCA records.

  • Charges

    A charge with Hdfc Bank Limited amounted to Rs. 2.43 M with Charge ID 100755689 was registered on 24 May 2023.

  • Balance Sheet

    Unitas Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Delhi.

  • Charges

    A charge with Others of Rs. 27.37 M registered on 30 Jul 2013 with Charge ID 10450560 was modified on 07 Aug 2020.

  • Charges

    A charge with Others amounted to Rs. 27.37 M with Charge ID 10450560 was registered on 30 Jul 2013.

  • Charges

    A charge with State Bank Of India of Rs. 21.50 M registered on 02 Apr 2003 with Charge ID 90058088 was modified on 26 Mar 2011.

Frequently asked questions

  • What is the Incorporation or founding date of Unitas Pharmaceuticals Private Limited?

    Unitas Pharmaceuticals Private Limited was incorporated on 02 Mar 1994.

  • What is authorized share capital and paid-up capital of Unitas Pharmaceuticals Private Limited?

    The authorized share capital of Unitas Pharmaceuticals Private Limited is ₹ 6.00 M and paid-up capital is ₹ 5.21 M.

  • Who are the current board members & directors of Unitas Pharmaceuticals Private Limited?

    Currently 2 directors are associated with Unitas Pharmaceuticals Private Limited.

    • Neelam Nijhawan
    • Akhilesh Chander Nagar
  • What is the registered address of Unitas Pharmaceuticals Private Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Unitas Pharmaceuticals Private Limited is R-28, Inderpuri India, New Delhi, 110012.

  • What is the corporate identification number (CIN) and company number of Unitas Pharmaceuticals Private Limited?

    The corporate identification number (CIN) of Unitas Pharmaceuticals Private Limited is U74899DL1994PTC057671 and the company number is 057671 as per Ministry of Corporate Affairs (MCA).

  • What has been the recent revenue trend for Unitas Pharmaceuticals Private Limited?

    According to the financial reports for the fiscal year 2023, the revenue trend for Unitas Pharmaceuticals Private Limited has fallen by -3.00%.

  • What change has been observed in the net worth of Unitas Pharmaceuticals Private Limited, and by what percentage?

    The financial reports for the fiscal year 2023 indicates that The net worth of Unitas Pharmaceuticals Private Limited has experienced an upsurge of 126.54%.

  • What are the total open charges for Unitas Pharmaceuticals Private Limited?

    As per the financial statements for fiscal Year 2023, The total open charges for Unitas Pharmaceuticals Private Limited amount to ₹ 5.13 Cr.

  • When was the last Balance Sheet of Unitas Pharmaceuticals Private Limited filed with the ROC?

    The most recent Balance Sheet for Unitas Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2023.